Exhibitors for 2022
Situated in the Education Hall. The BCS Exhibition is an integral part of the conference, providing delegates with the opportunity to converse with industry experts about development and research in cardiovascular products and innovation.
BCS Floor Plan
Please click here to access the floor plan for the BCS Conference.
A. Menarini Farmaceutica Internazionale SRL is one of Europe’s leading pharmaceutical companies with headquarters in Florence, Italy. The Menarini Group is present in 136 countries wordwide employing over 17,000 people. We’re dedicated to launching products that respond to the medical needs of patients and physicians.
Stand no: 4
Tel: 07525 944 262
AliveCor is a global leader in clinically validated personal ECG technology, delivering intelligent, personalised heart data – anytime, anywhere. We’re transforming cardiological care and are proud to offer KardiaMobile: the first and only NICE recommended personal ECG. Learn more: https://www.alivecor.co.uk/resource-hub
Stand no: 24
“Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From our scientific research foundation to our focus on clinical trials, and now our commercial expansion, we are evolving and growing rapidly, committed to reducing cardiovascular risk and making a meaningful impact on patients’ lives.”
Stand no: 14
Company: Amicus Therapeutics
Stand no: 11
Tel: 01753 888567
Email: email@example.com firstname.lastname@example.org
Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases
Stand no: CS2
Stand no: 28
Boehringer Ingelheim and Eli Lilly and Company have an alliance that centres on disease areas of diabetes and heart failure. By joining forces, the companies demonstrated their commitment in the improvement of patient care to address the areas of unmet medical need.
British Heart Foundation
The BHF use donations from the public to fund live-saving research for people affected by, or at risk of developing, cardiovascular disease. For 60 years we have funded the best ideas from the brightest scientists to help transform them into life-saving breakthroughs. But there’s still so much more to do.
Stand no: 8
British Society of Echocardiography
We represent and support clinical echocardiography professionals working at all levels and in all areas of the field. Our aim is to provide our members with the necessary support to deliver the highest standard of care in echocardiography. We are a leading provider of education and accreditation and produce guidelines and resources to promote best practice.
Stand no: CS4
Tel: 020 8565 5794
The British Society for Heart Failure supports professionals across the UK to advance research, education and policy in heart failure care. Visit our website to discover the benefits of becoming a member and access our resources. Join our campaign 'Freedom from Failure' together we can improve health outcomes and make heart failure a national priority.
Stand no: CS1
Tel: 020 3606 0798
The promotional symposium (organised and funded by Bristol-Myers Squibb/Pfizer Alliance), MDT management of ischaemic risk in patients with NVAF, involves a case study of a newly diagnosed patient with NVAF. The Alliance combines BMS's strengths in cardiovascular drug development and commercialisation with Pfizer’s global scale and expertise in this field.
May 2022 | 432-GB-2200188
Stand no: 7
Tel: 07768 926 561
We’re here for everyone affected by cardiomyopathy. We are the specialist national charity for people affected by cardiomyopathy, a condition that affects the heart muscle. Our vision is that everyone affected by cardiomyopathy should live a long and fulfilling life.
Stand no: CS3
Tel: 0800 018 1024
Like a heartbeat, our lives are full of countless precious moments. We at Daiichi Sankyo know how much each one matters. That’s why we’re committed to bringing cardiovascular therapeutic options to patients, partnering with those that stand beside them to ensure no one misses out on living life to the fullest.
Tel: 01895 910500
Website: DS UK | Daiichi Sankyo (daiichi-sankyo.co.uk)
Data4NHS maintains one of the largest healthcare related databases in the UK. Registration is free and only available to NHS professionals with a valid NHS email address. Register with us to have access to our resources including the Data4NHS national directory, recruitment opportunities, events and courses calendar, surveys and e-bulletin.
Stand no: 15
Tel: 0203 950 1017
Stand no: 22
FUJIFILM Healthcare UK Ltd
Fujifilm Healthcare presents LISENDO 880 cardiac ultrasound.
The LISENDO 880 is Fujifilm’s premium 2D/4D diagnostic ultrasound solution redefining the vision of cardiac ultrasound by providing exceptional clinical performance coupled with state-of-the-art features, a unique analytics package and precise quantification tools. Streamline your examination and enhance patient care. The next level in cardiovascular diagnosis.
Tel: 0844 800 4294
At Janssen we are working towards a new era for pulmonary arterial hypertension (PAH), including congenital heart disease associated-PAH. Our aim is to improve patient pathways which may reduce delays in diagnosis and transform the disease into a long-term manageable condition so that patients can live a normal life.
Stand no: 42
iRhythm Technologies is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable bio-sensing technology with cloud-based data analytics and AI capabilities. Our goal is to be the leading provider of first-line ambulatory electrocardiogram (ECG) for patients at risk of cardiac arrhythmias.
Stand no: 40
Tel: 0808 189 3411
Medscape UK is the leading online destination for physicians and healthcare professionals, offering the latest medical news and expert perspectives; essential point-of-care drug and disease information; and relevant professional education and CME.
Medscape membership is free, and you will be joining a vibrant UK community, with thousands of physicians and healthcare professional and millions in the Medscape network worldwide.
Stand no.: 18
We fuse technology, a deep understanding of the body, and leading medical science to create never-before-seen solutions. Whether it’s less invasive surgical approaches to minimise a patient's downtime or creating the smallest pacemaker, our potential to transform lives knows no limits.
Stand no.: 6
Tel: 01923 212213
Nanosonics’ mission is to improve safety of patients, clinics & their staff, and the environment by transforming the way infection prevention practices are conducted. Thus, today we are introducing to the UK market, an innovative technology that delivers improved standards of care to Cardiology practises with the Soluscope TEE Machine.
Tel: +44 1484 860 581
Nova Biomedical develops fast, whole blood analysers to support the care of hospitalised and critically ill patients. Offering the most extensive stat test menus, and delivering results in the shortest time at the lowest costs, Nova analysers can help to improve patient outcomes while reducing the overall cost of care.
Stand no.: 32
Tel: 01928 704040
As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments.
In the UK, we employ approximately 1,300 people to serve healthcare needs across the whole of the UK, as well as supporting the global operations of Novartis. Since 2014, Novartis has invested over £200 million in R&D and is the single largest industry sponsor of clinical trials in the UK.
Stand no: 1
Tel: +44 1276 692255
Philips is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care.
Stand no: 12
Tel 01253 501035
At the SCST, advancing cardiac science is our goal. We’re the not-for-profit professional body for all those working in the field of clinical cardiac science. The voice of scientists, physiologists, and practitioners; promoting excellence within the field, advancing education, and supporting our members. Come join us!
Stand no.: CS6
Tel: 020 7380 1934 – Membership Enquiries
The United Kingdom Accreditation Service (UKAS) is the sole National Accreditation Body for the UK. Its role is to check that organisations providing conformity assessment services (certification, testing, inspection and calibration) are meeting a required standard of performance. UKAS accreditation demonstrates an organisation’s competence, impartiality and performance capability against internationally recognised standards. For further information please visit www.ukas.com.
Stand no.: 36
Tel: 01784 429000
The Virtual Cath Lab
Designed and operated by cardiologists, for cardiologists that are passionate about providing the very latest CT technology to diagnose and prevent heart disease.
VCL has OEM, workstation, and industry ‘know-how’ - all that is required to replicate our flagship high quality cardiac scan service for other cardiology groups, anywhere.
Stand no.: 16
Women in Cardiology
The British Cardiovascular Society Women in Cardiology team are passionate about supporting women working within cardiology and encouraging more women to join the specialty. Their aim is to promote gender equality within cardiology at a local, national and international level.
Stand no.: 30
Website: BCS Women in Cardiology
Zenicor-ECG is a solution developed to be utilised by health care professionals for effective diagnosis of cardiac arrhythmias, including atrial fibrillation. Zenicor-ECG has been the chosen solution by large screening studies STROKESTOP I and II, as well as SAFER trial in the UK and SAFER-AUS. For more information visit: www.zenicor.com
Stand no: 26
Email: Abdirahman.email@example.com Kaisa.firstname.lastname@example.org